Delivery Order SPE2D018D0005-SPE2D324F6248

Award Date 2/21/24
Potential Completion Date 2/26/24
Potential Value $1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded a $1,037.23 firm fixed-price delivery order to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, for the supply of 150 mL Bioclone anti-D reagent. This order is not associated with any set-aside designation. Ortho-Clinical Diagnostics is a for-profit organization that has previously provided a variety of medical equipment, reagents, and services to federal agencies such as the Department of Veterans Affairs, Defense...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order for $5,186.15 to Ortho-Clinical Diagnostics Inc. for the purchase of 150 ML of REAGENT ANTI-D BIOCLONE. Ortho-Clinical Diagnostics Inc. is a medical equipment manufacturer that provides a range of diagnostic solutions, including immunodiagnostic and clinical chemistry systems, to federal agencies such as the Department of Veterans Affairs and Department of Health and Human Services. This delivery order...
<p>The Defense Logistics Agency Troop Support Medical awarded a $1,037.23 firm fixed price delivery order to Ortho-Clinical Diagnostics, Inc. to provide 150ml Reagent Anti-D Bioclone. Ortho-Clinical Diagnostics is a medical equipment manufacturer that has provided a range of diagnostic solutions, reagents, and services to various federal agencies. This contract has no set-aside designation and is scheduled for completion on February 21, 2024.</p>
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract worth $1,037.23 to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the supply of 150 ml vials of Reagent Anti-D Bioclone. The contract has a completion date of February 21, 2024. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that has provided a range of diagnostic solutions, including COVID-19 tests and immunodiagnostic equipment,...
The Defense Logistics Agency Troop Support Medical awarded a $5,186.15 firm fixed price delivery order to Ortho-Clinical Diagnostics Inc. for the procurement of 150ml REAGENT ANTI-D BIOCLONE. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including products and services to federal agencies such as the Department of Veterans Affairs and Defense Health Agency. This award was not designated as a set-aside contract. The performance...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the provision of 150 milliliters of reagent anti-D bioclone. The contract has a potential value of $1,037.23 and a completion date of February 27, 2024. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that provides a range of diagnostic solutions, including analyzers, reagents, and...
The Defense Logistics Agency Troop Support Medical awarded a $1,037.23 firm fixed price delivery order to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, for 150ML monoclonal REAGENT ANTI-D BIOCLONE. This product delivery order was not set aside. Ortho-Clinical Diagnostics, Inc. has provided a range of medical equipment, reagents, and testing services to federal agencies, including the Department of Veterans Affairs and Department of Health and Human Services,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc. for the delivery of 150 mL vials of REAGENT ANTI-D BIOCLONE. The contract has a completion date of February 26, 2024 and a potential value of $1,037.23. Ortho-Clinical Diagnostics, Inc. is a for-profit medical equipment manufacturer that provides diagnostic solutions, including to federal agencies such as the Department of Veterans Affairs and Defense Health...
This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency Troop Support to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,037.23 contract provides 150 milliliter bottles of Reagent Anti-D Bioclone, a critical diagnostic reagent. Ortho-Clinical Diagnostics has provided a range of medical equipment, reagents, and services to various federal healthcare agencies, including the Department of...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturing company, to provide 150ml of Reagent Anti-D Bioclone. The contract has a completion date of December 27, 2023 and a potential value of $5,186.15. Ortho-Clinical Diagnostics Inc. is a for-profit organization and self-certified HUBZone joint venture that manufactures a range of diagnostic solutions, including analyzers,...
  • SPE2D018D0005
    Indefinite Delivery Contract
  • SPE2D018D0005-SPE2D324F6248
    Delivery Order

The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order contract to Ortho-Clinical Diagnostics, Inc. for $1,037.23 to provide 150 ml of Reagent Anti-D Bioclone. Ortho-Clinical Diagnostics is a manufacturer of medical equipment and diagnostic solutions that has provided products and services to various federal agencies, including the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service. This delivery order is not associated with a set-aside program and is expected to be completed by February 26, 2024.

Generated 5/22/24, 9:29 AM